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  Brucella spp are a diverse group of gram negative pathogens causing disease in many hosts including humans. Vaccination against animal brucellosis is an important control strategy to prevent the disease. Research for novel vaccines has focused upon the development of live vaccine strains1. Based on their different clearance pattern in mice, 
some of the new Brucella species described lately2,3, were selected for being  potential candidate vaccines against brucellosis. THE AIM OF THIS WORK is to evaluate the 
efficacy induced by B. microti, B. ceti and B. pinnipedialis, against B. melitensis, in a murine model of infection. 
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MATERIALS AND METHODS 
Kinetics of infection. Female balb/c mice were intraperitonelly (ip) inoculated with 104  
colony forming units (cfu) of B. microti or 105 cfu of the following strains: B. ceti 
12891, B. pinnipedialis 12890, and B. pinnipedialis 22F1.  At selected times post 
inoculation animals were euthanized and their spleen and liver removed to determine 
cfu/organ (Figure 1).  
In vivo protection studies. In parallel, mice were vaccinated with the same strains and 
doses using the standard vaccine Rev 1 inoculated ip or subcutaneously (sc) as vaccine 
control. A lot remained unvaccinated. Half of the vaccinated animals were ip 
challenged 4 weeks later with 105 cfu of B. melitensis 16M wild type and the other half 
were similarly challenged 22 weeks later. One week after the challenge, spleens were 
aseptically removed and weighed  to determine the number of cfu/organ (Figure 3).  
In vitro studies. Correlates of protective immunity were evaluated via splenocyte 
cytokine memory responses at 4 and 22 weeks. Splenocytes isolated from vaccinated 
mice were stimulated with Heat Killed B. melitensis for 72 h and IFN-γ and TNF-α 
production were measured (Figure 2). 
Data are represented as Mean+SEM. * p<0.05, **p<0.01, ***p<0.001.  
 
RESULTS 
The used strains  showed different multiplication patterns  (Figure 1). All the new strains of Brucella tested induced protection against B. melitensis 16M at 4 and 22 weeks 
after vaccination independently on the clearance pattern (Figure 2). It was a correlation between protection induced and cytokine production at both time points (Figure 3). 
 
  CONCLUSION 
The new species of Brucella tested could be considered as potential candidates 
vaccines against B. melitensis.  
Moreover, cytokine production reflected a memory response with subsequent 
protection against challenge. 
Figure 1. Number of Brucella and weight of spleen (left) and liver (right) of mice inoculated ip 
with 105 cfu of B. ceti 12891, B. pinnipedialis 12890 and B. pinnipedialis 22F1 or 104 cfu B. 
microti and analysed at 7, 14, 21, 28, 56 and 84 days post-infection. (Mean+SD).  **p<0.01, 
***p<0.001. 
Figure 2. Concentration of IFN-γ and TNF-α produced by splenocytes isolated from mice 
inoculated ip with 105 cfu of B. ceti 12891, B. pinnipedialis 12890 and B. pinnipedialis 22F1 or 104 
cfu B. microti for 4 (left) or 22 (right) weeks and stimulated with Heat Killed B. melitensis for 72 h. 
(Mean+SD).  **p<0.005, ***p<0.001.  
Figure 3. Number of Brucella per spleen of mice inoculated ip with 105 cfu of B. ceti 12891, B. 
pinnipedialis 12890 and B. pinnipedialis 22F1 or 104 cfu B. microti for 4 (left) or 22 (right) weeks 
and challenged ip with 105 cfu of B. melitensis, analysed at 7 days post-infection. (Mean+SD).  
**p<0.005, ***p<0.001.  
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